CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale President and CEO sold 4,781 shares at $15.52 ($74,201)
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $15.47 ($38,675)
- 4 Open-market sale 10% owner sold 15,000 shares at $16.00 ($240,000)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale Director sold 5,000 shares at $14.61 ($73,050)
- 4 Open-market sale President and CEO sold 4,481 shares at $15.00 ($67,215)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- CT ORDER Other Confidential Order
- 4 Open-market sale President and CEO sold 300 shares at $15.00 ($4,500)
- 4 Grant or award President and CEO acquired 2,266 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 2,698 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 31 of 41 · 801 filings